Samala, Jack P.
HRN: 06-83-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/09/2024
03/16/2024
IV
600mg
Q6
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes